Is F85 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of F85 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: F85 (€16.6) is trading below our estimate of fair value (€205.73)
Significantly Below Fair Value: F85 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for F85?
Key metric: As F85 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for F85. This is calculated by dividing F85's market cap by their current
book value.
What is F85's PB Ratio?
PB Ratio
-16.9x
Book
-US$10.22m
Market Cap
US$172.18m
F85 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: F85 has negative equity and a Price-To-Book Ratio (-16.9x) compared to the European Metals and Mining industry average (0.9x).
Price to Book Ratio vs Fair Ratio
What is F85's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
F85 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
-16.9x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate F85's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst F85 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€16.60
€30.47
+83.6%
16.2%
€37.80
€23.63
n/a
6
Nov ’25
€19.60
€31.73
+61.9%
10.0%
€37.08
€27.51
n/a
6
Oct ’25
€17.20
€30.33
+76.3%
9.5%
€36.24
€26.88
n/a
6
Sep ’25
€19.20
€29.91
+55.8%
9.5%
€35.74
€26.51
n/a
6
Aug ’25
€20.80
€31.48
+51.4%
8.3%
€35.15
€27.44
n/a
5
Jul ’25
€16.50
€31.92
+93.5%
9.2%
€35.50
€27.72
n/a
4
Jun ’25
€22.20
€32.15
+44.8%
9.0%
€34.99
€27.32
n/a
4
May ’25
€19.60
€29.98
+53.0%
16.2%
€35.44
€21.66
n/a
5
Apr ’25
€17.70
€28.77
+62.5%
19.4%
€35.06
€21.42
n/a
4
Mar ’25
€15.40
€30.08
+95.3%
20.2%
€35.28
€21.56
n/a
3
Feb ’25
€16.05
€34.00
+111.8%
2.7%
€34.92
€33.08
n/a
2
Jan ’25
n/a
€32.21
0%
9.8%
€35.30
€27.87
n/a
3
Dec ’24
n/a
€32.58
0%
9.8%
€35.71
€28.19
€16.60
3
Nov ’24
n/a
€32.58
0%
9.8%
€35.71
€28.19
€19.60
3
Oct ’24
n/a
€32.58
0%
9.8%
€35.71
€28.19
€17.20
3
Sep ’24
n/a
€30.74
0%
11.8%
€34.35
€27.12
€19.20
2
Aug ’24
n/a
€30.74
0%
11.8%
€34.35
€27.12
€20.80
2
Jul ’24
n/a
€31.15
0%
11.8%
€34.82
€27.49
€16.50
2
Jun ’24
n/a
€31.75
0%
11.8%
€35.48
€28.01
€22.20
2
May ’24
n/a
€33.04
0%
4.1%
€34.39
€31.68
€19.60
2
Apr ’24
n/a
€34.05
0%
4.1%
€35.45
€32.65
€17.70
2
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.